Loading…
Maternally Administered Cyclic Glycine-Proline Increases Insulin-Like Growth Factor-1 Bioavailability and Novelty Recognition in Developing Offspring
Cyclic glycine-proline (cGP), a metabolite of IGF-1, is an endogenous neuropeptide that improves memory in adult rats. The presence and concentrations of endogenous cGP, and its association with IGF-1 and IGF binding protein-3 (IGFBP-3) in rat milk and plasma, were evaluated during postnatal develop...
Saved in:
Published in: | Endocrinology (Philadelphia) 2016-08, Vol.157 (8), p.3130-3139 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c536t-748685a66608349929011e29f659c6b6eeb58a50f548c2161e356b577fb4fd733 |
---|---|
cites | cdi_FETCH-LOGICAL-c536t-748685a66608349929011e29f659c6b6eeb58a50f548c2161e356b577fb4fd733 |
container_end_page | 3139 |
container_issue | 8 |
container_start_page | 3130 |
container_title | Endocrinology (Philadelphia) |
container_volume | 157 |
creator | Singh-Mallah, Gagandeep Singh, Kuljeet McMahon, Christopher D Harris, Paul Brimble, Margaret A Thorstensen, Eric Guan, Jian |
description | Cyclic glycine-proline (cGP), a metabolite of IGF-1, is an endogenous neuropeptide that improves memory in adult rats. The presence and concentrations of endogenous cGP, and its association with IGF-1 and IGF binding protein-3 (IGFBP-3) in rat milk and plasma, were evaluated during postnatal development. Maternal-infantile transfer of cGP during lactation and its efficacy on the memory of developing offspring were also investigated. Dams were gavaged with either cGP (3 mg/kg) or saline daily from postnatal days 8–22. Concentrations of cGP were measured in dams' milk, and concentrations of cGP, IGF-1, and IGFBP-3 were measured in the plasma of dams, pups, and young adults. The recognition memory, locomotor function, and anxiety-like behavior of offspring were evaluated using behavioral tests. Endogenous cGP was detected in rat milk, and its concentration was higher during peak lactation compared with late lactation. Comparisons within control groups showed low endogenous IGF-1 and IGFBP-3 and high endogenous cGP concentrations in the plasma of male pups. The reduced IGFBP-3 and increased cGP may be a response to increase the bioavailability of IGF-1 during infancy. Exogenous cGP showed oral bioavailability and effective maternal-infantile transfer through milk. Maternally transferred cGP also led to improved recognition memory in the developing offspring, possibly through increased IGF-1 bioavailability, with no effect on locomotor activity and anxiety-like behavior. These results show that cGP is an essential endogenous peptide during early postnatal development as it improves the bioavailability of IGF-1 during infancy. Furthermore, maternal cGP supplementation offers an effective and natural route of administration for improving memory in the developing offspring. |
doi_str_mv | 10.1210/en.2016-1189 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1897391435</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1210/en.2016-1189</oup_id><sourcerecordid>1808387434</sourcerecordid><originalsourceid>FETCH-LOGICAL-c536t-748685a66608349929011e29f659c6b6eeb58a50f548c2161e356b577fb4fd733</originalsourceid><addsrcrecordid>eNqNkUtv1DAUhSMEotPCjjWyxAIWuNjxK1mWgQ6VBooQrCPHuSkuHju1k1b5IfxfHM0AEgKJ1X3o0_HxPUXxhJJTWlLyCvxpSajElFb1vWJFay6woorcL1aEUIZVWaqj4jil6zxyztnD4qhUTAhe01Xx_b0eIXrt3IzOup31NuUZOrSejbMGbdxsrAf8MQaXK7rwJoJOkHKXprzCW_sN0CaGu_ErOtdmDBFT9NoGfaut0611dpyR9h36EG7B5f4TmHDl7WiDR9ajN5DXYbD-Cl32fRpi7h4VD3rtEjw-1JPiy_nbz-t3eHu5uVifbbERTI5Y8UpWQkspScV4XZc1oRTKupeiNrKVAK2otCC94JUpqaTAhGyFUn3L-04xdlK82OsOMdxMkMZmZ5MB57SHMKUmn1SxmnIm_gPNHirFGc_osz_Q6zAtN04No4woygRd3n65p0wMKUXom_z1nY5zQ0mzJNuAb5ZkmyXZjD89iE7tDrpf8M8oM_B8D4Rp-JcUPkixPQm-CybfG4YIKf12-VcDPwCJbLuF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3130713513</pqid></control><display><type>article</type><title>Maternally Administered Cyclic Glycine-Proline Increases Insulin-Like Growth Factor-1 Bioavailability and Novelty Recognition in Developing Offspring</title><source>Oxford Journals Online</source><creator>Singh-Mallah, Gagandeep ; Singh, Kuljeet ; McMahon, Christopher D ; Harris, Paul ; Brimble, Margaret A ; Thorstensen, Eric ; Guan, Jian</creator><creatorcontrib>Singh-Mallah, Gagandeep ; Singh, Kuljeet ; McMahon, Christopher D ; Harris, Paul ; Brimble, Margaret A ; Thorstensen, Eric ; Guan, Jian</creatorcontrib><description>Cyclic glycine-proline (cGP), a metabolite of IGF-1, is an endogenous neuropeptide that improves memory in adult rats. The presence and concentrations of endogenous cGP, and its association with IGF-1 and IGF binding protein-3 (IGFBP-3) in rat milk and plasma, were evaluated during postnatal development. Maternal-infantile transfer of cGP during lactation and its efficacy on the memory of developing offspring were also investigated. Dams were gavaged with either cGP (3 mg/kg) or saline daily from postnatal days 8–22. Concentrations of cGP were measured in dams' milk, and concentrations of cGP, IGF-1, and IGFBP-3 were measured in the plasma of dams, pups, and young adults. The recognition memory, locomotor function, and anxiety-like behavior of offspring were evaluated using behavioral tests. Endogenous cGP was detected in rat milk, and its concentration was higher during peak lactation compared with late lactation. Comparisons within control groups showed low endogenous IGF-1 and IGFBP-3 and high endogenous cGP concentrations in the plasma of male pups. The reduced IGFBP-3 and increased cGP may be a response to increase the bioavailability of IGF-1 during infancy. Exogenous cGP showed oral bioavailability and effective maternal-infantile transfer through milk. Maternally transferred cGP also led to improved recognition memory in the developing offspring, possibly through increased IGF-1 bioavailability, with no effect on locomotor activity and anxiety-like behavior. These results show that cGP is an essential endogenous peptide during early postnatal development as it improves the bioavailability of IGF-1 during infancy. Furthermore, maternal cGP supplementation offers an effective and natural route of administration for improving memory in the developing offspring.</description><identifier>ISSN: 0013-7227</identifier><identifier>EISSN: 1945-7170</identifier><identifier>DOI: 10.1210/en.2016-1189</identifier><identifier>PMID: 27355491</identifier><language>eng</language><publisher>United States: Endocrine Society</publisher><subject>Animals ; Anxiety ; Bioavailability ; Biological Availability ; Breastfeeding & lactation ; Effectiveness ; Exploratory Behavior - drug effects ; Female ; Glycine ; Glycine - administration & dosage ; Glycine - pharmacology ; Growth factors ; Insulin-like growth factor I ; Insulin-Like Growth Factor I - metabolism ; Insulin-Like Growth Factor I - pharmacokinetics ; Insulin-like growth factor-binding protein 3 ; Insulin-like growth factors ; Juveniles ; Lactation ; Locomotor activity ; Male ; Maternal Nutritional Physiological Phenomena ; Metabolites ; Milk ; Offspring ; Peptides, Cyclic - administration & dosage ; Peptides, Cyclic - pharmacology ; Postpartum period ; Pregnancy ; Prenatal Exposure Delayed Effects - metabolism ; Prenatal Exposure Delayed Effects - psychology ; Proline ; Proline - administration & dosage ; Proline - pharmacology ; Rats ; Rats, Sprague-Dawley ; Recognition ; Recognition (Psychology) - drug effects ; Young adults</subject><ispartof>Endocrinology (Philadelphia), 2016-08, Vol.157 (8), p.3130-3139</ispartof><rights>Copyright © 2016 by the Endocrine Society</rights><rights>Copyright © 2016 by the Endocrine Society 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c536t-748685a66608349929011e29f659c6b6eeb58a50f548c2161e356b577fb4fd733</citedby><cites>FETCH-LOGICAL-c536t-748685a66608349929011e29f659c6b6eeb58a50f548c2161e356b577fb4fd733</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27355491$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Singh-Mallah, Gagandeep</creatorcontrib><creatorcontrib>Singh, Kuljeet</creatorcontrib><creatorcontrib>McMahon, Christopher D</creatorcontrib><creatorcontrib>Harris, Paul</creatorcontrib><creatorcontrib>Brimble, Margaret A</creatorcontrib><creatorcontrib>Thorstensen, Eric</creatorcontrib><creatorcontrib>Guan, Jian</creatorcontrib><title>Maternally Administered Cyclic Glycine-Proline Increases Insulin-Like Growth Factor-1 Bioavailability and Novelty Recognition in Developing Offspring</title><title>Endocrinology (Philadelphia)</title><addtitle>Endocrinology</addtitle><description>Cyclic glycine-proline (cGP), a metabolite of IGF-1, is an endogenous neuropeptide that improves memory in adult rats. The presence and concentrations of endogenous cGP, and its association with IGF-1 and IGF binding protein-3 (IGFBP-3) in rat milk and plasma, were evaluated during postnatal development. Maternal-infantile transfer of cGP during lactation and its efficacy on the memory of developing offspring were also investigated. Dams were gavaged with either cGP (3 mg/kg) or saline daily from postnatal days 8–22. Concentrations of cGP were measured in dams' milk, and concentrations of cGP, IGF-1, and IGFBP-3 were measured in the plasma of dams, pups, and young adults. The recognition memory, locomotor function, and anxiety-like behavior of offspring were evaluated using behavioral tests. Endogenous cGP was detected in rat milk, and its concentration was higher during peak lactation compared with late lactation. Comparisons within control groups showed low endogenous IGF-1 and IGFBP-3 and high endogenous cGP concentrations in the plasma of male pups. The reduced IGFBP-3 and increased cGP may be a response to increase the bioavailability of IGF-1 during infancy. Exogenous cGP showed oral bioavailability and effective maternal-infantile transfer through milk. Maternally transferred cGP also led to improved recognition memory in the developing offspring, possibly through increased IGF-1 bioavailability, with no effect on locomotor activity and anxiety-like behavior. These results show that cGP is an essential endogenous peptide during early postnatal development as it improves the bioavailability of IGF-1 during infancy. Furthermore, maternal cGP supplementation offers an effective and natural route of administration for improving memory in the developing offspring.</description><subject>Animals</subject><subject>Anxiety</subject><subject>Bioavailability</subject><subject>Biological Availability</subject><subject>Breastfeeding & lactation</subject><subject>Effectiveness</subject><subject>Exploratory Behavior - drug effects</subject><subject>Female</subject><subject>Glycine</subject><subject>Glycine - administration & dosage</subject><subject>Glycine - pharmacology</subject><subject>Growth factors</subject><subject>Insulin-like growth factor I</subject><subject>Insulin-Like Growth Factor I - metabolism</subject><subject>Insulin-Like Growth Factor I - pharmacokinetics</subject><subject>Insulin-like growth factor-binding protein 3</subject><subject>Insulin-like growth factors</subject><subject>Juveniles</subject><subject>Lactation</subject><subject>Locomotor activity</subject><subject>Male</subject><subject>Maternal Nutritional Physiological Phenomena</subject><subject>Metabolites</subject><subject>Milk</subject><subject>Offspring</subject><subject>Peptides, Cyclic - administration & dosage</subject><subject>Peptides, Cyclic - pharmacology</subject><subject>Postpartum period</subject><subject>Pregnancy</subject><subject>Prenatal Exposure Delayed Effects - metabolism</subject><subject>Prenatal Exposure Delayed Effects - psychology</subject><subject>Proline</subject><subject>Proline - administration & dosage</subject><subject>Proline - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Recognition</subject><subject>Recognition (Psychology) - drug effects</subject><subject>Young adults</subject><issn>0013-7227</issn><issn>1945-7170</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqNkUtv1DAUhSMEotPCjjWyxAIWuNjxK1mWgQ6VBooQrCPHuSkuHju1k1b5IfxfHM0AEgKJ1X3o0_HxPUXxhJJTWlLyCvxpSajElFb1vWJFay6woorcL1aEUIZVWaqj4jil6zxyztnD4qhUTAhe01Xx_b0eIXrt3IzOup31NuUZOrSejbMGbdxsrAf8MQaXK7rwJoJOkHKXprzCW_sN0CaGu_ErOtdmDBFT9NoGfaut0611dpyR9h36EG7B5f4TmHDl7WiDR9ajN5DXYbD-Cl32fRpi7h4VD3rtEjw-1JPiy_nbz-t3eHu5uVifbbERTI5Y8UpWQkspScV4XZc1oRTKupeiNrKVAK2otCC94JUpqaTAhGyFUn3L-04xdlK82OsOMdxMkMZmZ5MB57SHMKUmn1SxmnIm_gPNHirFGc_osz_Q6zAtN04No4woygRd3n65p0wMKUXom_z1nY5zQ0mzJNuAb5ZkmyXZjD89iE7tDrpf8M8oM_B8D4Rp-JcUPkixPQm-CybfG4YIKf12-VcDPwCJbLuF</recordid><startdate>201608</startdate><enddate>201608</enddate><creator>Singh-Mallah, Gagandeep</creator><creator>Singh, Kuljeet</creator><creator>McMahon, Christopher D</creator><creator>Harris, Paul</creator><creator>Brimble, Margaret A</creator><creator>Thorstensen, Eric</creator><creator>Guan, Jian</creator><general>Endocrine Society</general><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201608</creationdate><title>Maternally Administered Cyclic Glycine-Proline Increases Insulin-Like Growth Factor-1 Bioavailability and Novelty Recognition in Developing Offspring</title><author>Singh-Mallah, Gagandeep ; Singh, Kuljeet ; McMahon, Christopher D ; Harris, Paul ; Brimble, Margaret A ; Thorstensen, Eric ; Guan, Jian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c536t-748685a66608349929011e29f659c6b6eeb58a50f548c2161e356b577fb4fd733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Anxiety</topic><topic>Bioavailability</topic><topic>Biological Availability</topic><topic>Breastfeeding & lactation</topic><topic>Effectiveness</topic><topic>Exploratory Behavior - drug effects</topic><topic>Female</topic><topic>Glycine</topic><topic>Glycine - administration & dosage</topic><topic>Glycine - pharmacology</topic><topic>Growth factors</topic><topic>Insulin-like growth factor I</topic><topic>Insulin-Like Growth Factor I - metabolism</topic><topic>Insulin-Like Growth Factor I - pharmacokinetics</topic><topic>Insulin-like growth factor-binding protein 3</topic><topic>Insulin-like growth factors</topic><topic>Juveniles</topic><topic>Lactation</topic><topic>Locomotor activity</topic><topic>Male</topic><topic>Maternal Nutritional Physiological Phenomena</topic><topic>Metabolites</topic><topic>Milk</topic><topic>Offspring</topic><topic>Peptides, Cyclic - administration & dosage</topic><topic>Peptides, Cyclic - pharmacology</topic><topic>Postpartum period</topic><topic>Pregnancy</topic><topic>Prenatal Exposure Delayed Effects - metabolism</topic><topic>Prenatal Exposure Delayed Effects - psychology</topic><topic>Proline</topic><topic>Proline - administration & dosage</topic><topic>Proline - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Recognition</topic><topic>Recognition (Psychology) - drug effects</topic><topic>Young adults</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Singh-Mallah, Gagandeep</creatorcontrib><creatorcontrib>Singh, Kuljeet</creatorcontrib><creatorcontrib>McMahon, Christopher D</creatorcontrib><creatorcontrib>Harris, Paul</creatorcontrib><creatorcontrib>Brimble, Margaret A</creatorcontrib><creatorcontrib>Thorstensen, Eric</creatorcontrib><creatorcontrib>Guan, Jian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrinology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Singh-Mallah, Gagandeep</au><au>Singh, Kuljeet</au><au>McMahon, Christopher D</au><au>Harris, Paul</au><au>Brimble, Margaret A</au><au>Thorstensen, Eric</au><au>Guan, Jian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Maternally Administered Cyclic Glycine-Proline Increases Insulin-Like Growth Factor-1 Bioavailability and Novelty Recognition in Developing Offspring</atitle><jtitle>Endocrinology (Philadelphia)</jtitle><addtitle>Endocrinology</addtitle><date>2016-08</date><risdate>2016</risdate><volume>157</volume><issue>8</issue><spage>3130</spage><epage>3139</epage><pages>3130-3139</pages><issn>0013-7227</issn><eissn>1945-7170</eissn><abstract>Cyclic glycine-proline (cGP), a metabolite of IGF-1, is an endogenous neuropeptide that improves memory in adult rats. The presence and concentrations of endogenous cGP, and its association with IGF-1 and IGF binding protein-3 (IGFBP-3) in rat milk and plasma, were evaluated during postnatal development. Maternal-infantile transfer of cGP during lactation and its efficacy on the memory of developing offspring were also investigated. Dams were gavaged with either cGP (3 mg/kg) or saline daily from postnatal days 8–22. Concentrations of cGP were measured in dams' milk, and concentrations of cGP, IGF-1, and IGFBP-3 were measured in the plasma of dams, pups, and young adults. The recognition memory, locomotor function, and anxiety-like behavior of offspring were evaluated using behavioral tests. Endogenous cGP was detected in rat milk, and its concentration was higher during peak lactation compared with late lactation. Comparisons within control groups showed low endogenous IGF-1 and IGFBP-3 and high endogenous cGP concentrations in the plasma of male pups. The reduced IGFBP-3 and increased cGP may be a response to increase the bioavailability of IGF-1 during infancy. Exogenous cGP showed oral bioavailability and effective maternal-infantile transfer through milk. Maternally transferred cGP also led to improved recognition memory in the developing offspring, possibly through increased IGF-1 bioavailability, with no effect on locomotor activity and anxiety-like behavior. These results show that cGP is an essential endogenous peptide during early postnatal development as it improves the bioavailability of IGF-1 during infancy. Furthermore, maternal cGP supplementation offers an effective and natural route of administration for improving memory in the developing offspring.</abstract><cop>United States</cop><pub>Endocrine Society</pub><pmid>27355491</pmid><doi>10.1210/en.2016-1189</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0013-7227 |
ispartof | Endocrinology (Philadelphia), 2016-08, Vol.157 (8), p.3130-3139 |
issn | 0013-7227 1945-7170 |
language | eng |
recordid | cdi_proquest_miscellaneous_1897391435 |
source | Oxford Journals Online |
subjects | Animals Anxiety Bioavailability Biological Availability Breastfeeding & lactation Effectiveness Exploratory Behavior - drug effects Female Glycine Glycine - administration & dosage Glycine - pharmacology Growth factors Insulin-like growth factor I Insulin-Like Growth Factor I - metabolism Insulin-Like Growth Factor I - pharmacokinetics Insulin-like growth factor-binding protein 3 Insulin-like growth factors Juveniles Lactation Locomotor activity Male Maternal Nutritional Physiological Phenomena Metabolites Milk Offspring Peptides, Cyclic - administration & dosage Peptides, Cyclic - pharmacology Postpartum period Pregnancy Prenatal Exposure Delayed Effects - metabolism Prenatal Exposure Delayed Effects - psychology Proline Proline - administration & dosage Proline - pharmacology Rats Rats, Sprague-Dawley Recognition Recognition (Psychology) - drug effects Young adults |
title | Maternally Administered Cyclic Glycine-Proline Increases Insulin-Like Growth Factor-1 Bioavailability and Novelty Recognition in Developing Offspring |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T12%3A45%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Maternally%20Administered%20Cyclic%20Glycine-Proline%20Increases%20Insulin-Like%20Growth%20Factor-1%20Bioavailability%20and%20Novelty%20Recognition%20in%20Developing%20Offspring&rft.jtitle=Endocrinology%20(Philadelphia)&rft.au=Singh-Mallah,%20Gagandeep&rft.date=2016-08&rft.volume=157&rft.issue=8&rft.spage=3130&rft.epage=3139&rft.pages=3130-3139&rft.issn=0013-7227&rft.eissn=1945-7170&rft_id=info:doi/10.1210/en.2016-1189&rft_dat=%3Cproquest_cross%3E1808387434%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c536t-748685a66608349929011e29f659c6b6eeb58a50f548c2161e356b577fb4fd733%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3130713513&rft_id=info:pmid/27355491&rft_oup_id=10.1210/en.2016-1189&rfr_iscdi=true |